Skip to content

The Effect of Psychosocial Skills Focused Group Psychoeducation in Schizophrenia Patients

The Effect of Psychosocial Skills Focused Group Psychoeducation on Functional Improvement, Treatment Compliance and Mental Well-Being in Schizophrenia Patients: a Randomised Controlled Study

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06872424
Acronym
Schizophrenia
Enrollment
34
Registered
2025-03-12
Start date
2025-04-15
Completion date
2025-08-15
Last updated
2025-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional Status, Mental Development, Psychoeducation, Schizophrenia Patients, Treatment Outcome

Keywords

Schizophrenia, Psychoeducation, Functional recovery, Treatment adherence, Mental well-being

Brief summary

The aim of this study was to evaluate the effect of psychosocial skills-oriented group psychoeducation on functional recovery, treatment adherence and mental well-being in patients with schizophrenia. This research will be conducted in Giresun Community Mental Health Center. The study was planned as a randomized controlled pretest-posttest design. In addition to the Sociodemographic Information Form prepared by the researchers, the Functional Recovery Scale in Schizophrenia, the Modified Morisky Treatment Adherence Scale and the Warwick-Edinburgh Mental Well-Being Scale will be used to collect the data. The sample size was calculated as 34 people (experimental group= 17, control group= 17). Forms and scales will be applied to the experimental and control groups before psychoeducation and scales will be applied again to both groups after psychoeducation.

Detailed description

The aim of this study was to evaluate the effect of psychosocial skills-oriented group psychoeducation on functional recovery, treatment adherence and mental well-being in patients with schizophrenia. This research will be conducted in Giresun Community Mental Health Center. The study was planned as a randomized controlled pretest-posttest design. In addition to the Sociodemographic Information Form prepared by the researchers, the Functional Recovery Scale in Schizophrenia, the Modified Morisky Treatment Adherence Scale and the Warwick-Edinburgh Mental Well-Being Scale will be used to collect the data. The sample size was calculated as 34 people (experimental group= 17, control group= 17). Forms and scales will be applied to the experimental and control groups before psychoeducation and scales will be applied again to both groups after psychoeducation. Forms and scales will be applied to the experimental and control groups before psychoeducation and scales will be applied again to both groups after psychoeducation. Thus, the effect of the psychoeducation program on the determined parameters will be evaluated. After the completion of the research, short-term counseling services will be provided to the control group in line with ethical principles. SPSS 25 package program will be used for data analysis.

Interventions

BEHAVIORALpsychosocial skills-oriented group psychoeducation

A 5-session Psychosocial Skills Focused Group Psychoeducation will be implemented, each session lasting approximately 60-90 minutes. In order to make the training more active and effective, the experimental group will be divided into small groups and divided into 3 groups and each group will be given 5 sessions of Psychosocial Skills Focused Group Psychoeducation once a week.

Sponsors

Gazi University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Intervention model description

Pre-test post-test control group study

Eligibility

Sex/Gender
ALL
Age
18 Weeks to No maximum
Healthy volunteers
No

Inclusion criteria

1. Having a diagnosis of schizophrenia according to DSM-5 diagnostic criteria 2. To have continuity in the Community Mental Health Center 3. Being in remission (period without psychotic exacerbation) as a result of the evaluation of the outpatient clinic doctor, 4. To be mentally capable of understanding the questions posed 5. To have the cognitive competence to understand the training provided 6. Not having any visual or auditory disability 7. Graduating from at least primary school

Exclusion criteria

1. Refusing to participate in the study 2. Being under 18 years of age 3. Being illiterate in Turkish 4. Having Mental Retardation

Design outcomes

Primary

MeasureTime frameDescription
Functional Recovery Scale in Schizophrenia1 dayFunctional Recovery Scale: The scale is 5-point Likert-type and consists of 19 items. The maximum score that can be obtained from the scale is 95 and the minimum score is 19. Patients who score below 58 points are considered to have a low level of Functional Recovery, patients who score between 59-65 points are considered to have a moderate level of Functional Recovery, and patients who score 66 points and above are considered to have a high level.
Morisky Treatment Adherence Scale1 dayMorisky Treatment Adherence Scale: The scale consists of 4 closed-ended questions with two options (yes/no). Medication adherence is assessed as high if no is answered to all questions (4 points), moderate if yes is answered to one or two questions (2-3 points), and low if yes is answered to three or four questions (0-1 pn).
Warwick-Edinburgh Mental Well-Being Scale1 dayWarwick-Edinburgh Mental Well-Being Scale: The scale consists of 14 items and each question is scored between 1-5. The total score range is 14-70. A higher score indicates a higher level of mental well-being.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026